Bildkälla: Stockfoto

OncoZenge: Down, but not out - Redeye

Redeye provides a research update following the Pharmanovia’s decision to discontinue the partnership with OncoZenge and not sign a definite commercial agreement. On the back end of this, we make some adjustments to our assumptions and estimates regarding financing, partnership deals and sales model.

Redeye provides a research update following the Pharmanovia’s decision to discontinue the partnership with OncoZenge and not sign a definite commercial agreement. On the back end of this, we make some adjustments to our assumptions and estimates regarding financing, partnership deals and sales model.
Börsvärldens nyhetsbrev
ANNONSER